Decisions made throughout early and mid-stage clinical trials impact late-stage results and sometimes, entire programs and companies. Since some obstacles can prove overwhelming for startups, there is a lot to learn from those who successfully walked the path.
In this Endpoints News webinar, we assembled a panel of experts to weigh in on:
- Gathering the right team to translate benchtop discoveries into clinical trials
- Choosing the right study design to position phase 1 safety data for phase 2 efficacy trials
- Planning clinical operations to manage diverse internal and external stakeholders
- CMC strategies to help drug products reach patients faster